Sign in with your email address username.


[Correspondence] Bivalirudin versus heparin use for patients undergoing PPCI

We congratulate Adeel Shahzad and colleagues (Nov 22, p 1849)1 on their remarkable achievement of enrolling almost 2000 patients with ST-segment elevation myocardial infarction (STEMI) and undergoing primary percutaneous coronary intervention (PPCI) into their trial, with minimal exclusions.